← All medicines

Transplant medicines

Narsoplimab-wuug injection

Independent educational summary · Sources checked November 20, 2026

An antibody treatment for specified stem-cell-transplant-associated thrombotic microangiopathy.

Profile scope: Narsoplimab-wuug injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Digestive symptoms, tiredness, weakness, or back discomfort may occur.

Serious risks and warning signs

Infection and unusual bleeding or bruising require immediate treatment-team advice. Transplant-related illness can also cause these symptoms, so the team must assess the cause and response. Do not independently alter transplant medicines.

A question for your healthcare team

Which infection and blood-count checks are planned, and how will improvement in the transplant complication be assessed?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.